BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Tuesday, April 28, 2026
Home » Authors » John Fox

Articles by John Fox

Ketamine discovery may yield fast-acting antidepressants

March 5, 2018
By John Fox

Ketamine discovery may yield fast-acting antidepressants

March 2, 2018
By John Fox
HONG KONG – A Chinese study has shown for the first time that the powerful antidepressant effects of ketamine are due to blockade of rapid neuronal firing in the brain's lateral habenula (LHb) region. Such blockade was found to disinhibit reward centers and relieve depressive symptoms rapidly in animal models.
Read More

Nanorobots deliver blood-curdling cancer therapy

Feb. 28, 2018
By John Fox
HONG KONG – Researchers led by the National Center for Nano-science Technology (NCNST), Chinese Academy of Sciences, have developed a DNA-based nanorobot and shown in mammals that it is a safe and effective means of delivering targeted cancer treatment in response to a molecular trigger.
Read More

Organ on a chip provides insight into hepatitis B virus

Feb. 28, 2018
By John Fox
HONG KONG – Scientists at Imperial College London are testing how the hepatitis B virus (HBV) interacts with the liver using new organ on a chip technology, which could lead to the future development of new treatments for HBV and other diseases.
Read More

Nanorobots deliver blood-curdling cancer therapy

Feb. 23, 2018
By John Fox

Nanorobots deliver blood-curdling cancer therapy

Feb. 23, 2018
By John Fox
Researchers led by the National Center for Nano-science Technology (NCNST), Chinese Academy of Sciences, have developed a DNA-based nanorobot and shown in mammals that it is a safe and effective means of delivering targeted cancer treatment in response to a molecular trigger.
Read More

Organ on a chip gives insight into hepatitis B virus

Feb. 22, 2018
By John Fox

Organ on a chip provides insight into hepatitis B virus

Feb. 22, 2018
By John Fox
Scientists at Imperial College London are testing how the hepatitis B virus (HBV) interacts with the liver using new organ on a chip technology, which could lead to the future development of new treatments for HBV and other diseases.
Read More

GWAS in Chinese population implicates immune system in Alzheimer's disease

Feb. 20, 2018
By John Fox

GWAS in Chinese population implicates immune system in Alzheimer's disease

Feb. 15, 2018
By John Fox
A study has identified common genetic variants in the Chinese population contributing to the risk of developing Alzheimer's disease (AD) that possibly exert functional effects through the immune system, which could have important implications for AD management.
Read More
Previous 1 2 … 24 25 26 27 28 29 30 31 32 … 68 69 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for April 28, 2026.
  • Illustration of a tumor

    Detecting the invisible: minimal residual disease at AACR 2026

    BioWorld Science
    Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for April 28, 2026
  • Sichuan Kelun Pharmaceutical Research Institute discovers GPR6 inverse agonists

    BioWorld Science
    Sichuan Kelun Pharmaceutical Research Institute Co. Ltd. has identified G protein-coupled receptor 6 (GPR6) inverse agonists reported to be useful for the...
  • Cerebral aneurysm illustration

    Grace Therapeutics hits CRL setback with GTx-104 despite positive trial

    BioWorld
    Grace Therapeutics Inc.’s hopes of becoming the first company in decades to update the standard of care in aneurysmal subarachnoid hemorrhage were delayed after...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing